4//SEC Filing
JANTZ DEREK 4
Accession 0001209191-22-035417
CIK 0001357874other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:42 PM ET
Size
13.3 KB
Accession
0001209191-22-035417
Insider Transaction Report
Form 4
JANTZ DEREK
DirectorChief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2022-06-07+12,199→ 4,074,023 total - Exercise/Conversion
Restricted Stock Units
2022-06-07−29,545→ 29,545 total→ Common Stock (29,545 underlying) - Sale
Common Stock
2022-06-08$2.06/sh−18,849$38,829→ 4,055,174 total - Exercise/Conversion
Common Stock
2022-06-07+29,545→ 4,061,824 total - Exercise/Conversion
Restricted Stock Units
2022-06-07−12,199→ 24,391 total→ Common Stock (12,199 underlying)
Footnotes (5)
- [F1]Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2022.
- [F2]Each RSU represents a contingent right to receive one share of the Company's Common Stock.
- [F3]The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
- [F4]On June 7, 2021 the Reporting person was granted RSUs, which vest in two equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
- [F5]On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
Documents
Issuer
PRECISION BIOSCIENCES INC
CIK 0001357874
Entity typeother
Related Parties
1- filerCIK 0001769828
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:42 PM ET
- Size
- 13.3 KB